SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Humanm Antibodys:ABGX,MEDX, CAT , Morphosys....
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who wrote (13)2/22/2000 9:49:00 AM
From: Jongmans  Read Replies (1) of 23
 
Market valuations hMAbs companies compared...

Abgenix......................US$ 4.131 bln#
Medarex......................US$ 3.115 bln
MorphoSys....................US$ 1.920 bln
Cambridge Antibody Techn.....US4 706 mln
# excluding convertibles

Cambridge Antibody Technology, with collaborations with big pharma's and with several products under development including one in phase lll, seems to be heavily undervalued.

martin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News